@article{0de44eb725e84a888ab448d0b23c6a8d,
title = "Advances and unanswered questions in management of acute myeloid leukemia in older adults: A glimpse into the future",
keywords = "Acute myeloid leukemia, Geriatric assessment, Older adults, Patient-centered care, Precision oncology, Symptom science",
author = "Bhatt, {Vijaya Raj}",
note = "Funding Information: Vijaya Bhatt reports receiving consulting fees from Takeda , Omeros , Agios , Abbvie , Genentech , Partner Therapeutics , Rigel , Incyte and Partnership for Health Analytic Research, LLC (that has received funds from Jazz) , and research funding (institutional) from Jazz , Abbvie , Pfizer , Incyte , Tolero Pharmaceuticals, Inc. , and National Marrow Donor Program . Drug support for a trial is provided by Oncoceutics. Funding Information: This work was supported by the National Institute of General Medical Sciences, 1 U54 GM115458, which funds the Great Plains Institutional Development Award (IDeA) Clinical Translational Research (CTR) Network. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Vijaya Bhatt reports receiving consulting fees from Takeda, Omeros, Agios, Abbvie, Genentech, Partner Therapeutics, Rigel, Incyte and Partnership for Health Analytic Research, LLC (that has received funds from Jazz), and research funding (institutional) from Jazz, Abbvie, Pfizer, Incyte, Tolero Pharmaceuticals, Inc., and National Marrow Donor Program. Drug support for a trial is provided by Oncoceutics. Funding Information: This work was supported by the National Institute of General Medical Sciences , 1 U54 GM115458 , which funds the Great Plains Institutional Development Award (IDeA) Clinical Translational Research (CTR) Network. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. ",
year = "2021",
month = jul,
doi = "10.1016/j.jgo.2021.02.011",
language = "English (US)",
volume = "12",
pages = "980--984",
journal = "Journal of Geriatric Oncology",
issn = "1879-4068",
publisher = "Elsevier Limited",
number = "6",
}